Valuation: H&R GmbH & Co. KGaA

Market Cap 229M 266M 215M 196M 368M 25.39B 374M 2.52B 988M 12.72B 997M 976M 42.32B P/E 2026 *
4.77x
P/E 2027 * 16.7x
Enterprise Value 252M 292M 237M 215M 405M 27.93B 411M 2.77B 1.09B 13.99B 1.1B 1.07B 46.54B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.17x
Free-Float
21.97%
Yield 2026 *
0.81%
Yield 2027 * 0.81%
08-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-14 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25-08-24 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
25-08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
25-05-13 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-16 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
25-04-08 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-26 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
1 day+0.32%
1 week+2.32%
Current month+3.00%
1 month-4.04%
3 months+36.73%
6 months+38.57%
Current year+44.06%
1 week 5.86
Extreme 5.86
6.3
1 month 5.74
Extreme 5.74
6.68
Current year 3.91
Extreme 3.91
6.68
1 year 3.91
Extreme 3.91
6.68
3 years 3.23
Extreme 3.23
6.68
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 2015-12-31
Investor Relations Contact - 2005-12-31
Director TitleAgeSince
Chairman 62 2012-04-16
Director/Board Member 71 2011-04-30
Director/Board Member 69 2011-04-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+2.32%+23.11%+22.62% 265M
-0.86%-2.69%+1.95%+25.61% 124B
-3.37%+6.65%+366.82%+199.70% 51.43B
-1.16%-2.99%-13.40%-42.57% 40.11B
+0.12%-3.42%+16.10%-21.98% 33.9B
+0.17%-3.13%+47.65%+67.13% 24.68B
+0.04%+1.84%+20.49%-34.19% 20.6B
+4.46%+4.91%+379.64%+660.22% 19.4B
+0.16%+7.24%+32.45%+368.98% 18.9B
+2.25%-11.77%+57.15%+230.88% 18.01B
Average +0.21%+0.64%+93.20%+147.64% 35.13B
Weighted average by Cap. -0.53%-0.21%+84.63%+102.17%

Financials

2026 *2027 *
Net sales 1.4B 1.62B 1.31B 1.19B 2.24B 155B 2.27B 15.35B 6.01B 77.43B 6.07B 5.94B 258B 1.36B 1.58B 1.28B 1.16B 2.19B 151B 2.22B 14.98B 5.87B 75.59B 5.92B 5.8B 251B
Net income 39.5M 45.75M 37.06M 33.75M 63.46M 4.37B 64.34M 434M 170M 2.19B 172M 168M 7.29B 16.5M 19.11M 15.48M 14.1M 26.51M 1.83B 26.88M 181M 71.11M 916M 71.76M 70.2M 3.05B
Net Debt 22.87M 26.49M 21.45M 19.54M 36.74M 2.53B 37.25M 251M 98.55M 1.27B 99.45M 97.29M 4.22B 8.65M 10.02M 8.12M 7.39M 13.9M 958M 14.09M 95.14M 37.28M 480M 37.62M 36.81M 1.6B
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
26-08-17 6.180 +0.32% 6,060
26-08-14 €6.160 -0.65% 7,318
26-08-13 €6.200 +4.03% 13,119
26-08-12 €5.960 -1.97% 7,692
26-08-11 €6.080 +0.66% 171
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.160EUR
Average target price
7.500EUR
Spread / Average Target
+21.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock